Necroptosis: An emerging form of programmed cell death

Critical Reviews in Oncology/Hematology

Volumn 82, Issue 3, 2012, Pages 249-258

  Wu, Wei ^a   Liu, Peng ^a   Li, Jianyong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cancer; Cell death; Necroptosis

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; LIPOXYGENASE; NECROSTATIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROTEIN KINASE 1; PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REGULATOR PROTEIN; SUCCINATE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOPHAGY; CANCER CELL; CANCER RESISTANCE; CARCINOGENESIS; CELL PROTECTION; CELLULAR STRESS RESPONSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IMMUNOREGULATION; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; NECROPTOSIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION; HUMANS; IMIDAZOLES; INDOLES; NECROSIS; NUCLEAR PORE COMPLEX PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861195802     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2011.08.004     Document Type: Review

References (120)

1. Kroemer G., Galluzzi L., Vandenabeele P., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2009, 16:3-11.
2. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
3. Galluzzi L., Joza N., Tasdemir E., et al. No death without life:vital function of apoptotic effectors. Cell Death Differ 2009, 16:1093-1107.
4. Holler N., Zaru R., Micheau O., et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1:489-495.
5. Artus C., Boujrad H., Bouharrour A., et al. AIF promotes chromatinolysis and caspase-independent programmed necrosis by interacting with histone H2AX. EMBO J 2010, 29:1585-1599.
6. Zong W.X., Ditsworth D., Bauer D.E., Wang Z.Q., Thompson C.B. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004, 18:1223-1226.
7. Edinger A.L., Thompson C.B. Death by design:apoptosis, necrosis or autophagy. Curr Opin Cell Biol 2004, 16:663-669.
8. Galluzzi L., Kepp O., Kroemer G. RIP kinases initiate programmed necrosis. J Mol Cell Biol 2009, 1:8-10.
9. Degterev A., Hitomi J., Germscheid M., et al. Identification of RIP1 kinase as a specific cellular target of necrostations. Nat Chem Biol 2008, 4:313-321.
10. Fiers W., Beyaert R., Boone E., et al. TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J Inflamm 1995, 47:67-75.
11. Kalai M., Van Loo G., Vanden Berghe T., et al. Tipping the balance between necrosis and apoptosis in human and murine cells treated with interferon and dsDNA. Cell Death Differ 2002, 9:981-994.
12. Hitomi J., Christofferson D.E., Ng A., et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008, 135:1311-1323.
13. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296:1634-1635.
14. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975, 72:3666-3670.
15. Laster S.M., Wood J.G., Gooding L.R. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 1988, 141:2629-2634.
16. Andera L. Signaling activated by the death receptors of the TNFR family. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009, 153:173-180.
17. Chan F.K., Chun H.J., Zheng L., Siegel R.M., Bui K.L., Lenardo M.J. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 2000, 288:2351-2354.
18. Wertz I.E., Dixit V.M. Ubiquitin-mediated regulation of TNFR1 signaling. Cytokine Growth Factor Rev 2008, 19:313-324.
19. Mahoney D.J., Cheung H.H., Mrad R.L., et al. Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc Natl Acad Sci USA 2008, 105:11778-11783.
20. Varfolomeev E., Goncharov T., Fedorova A.V., et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha(TNFalpha)-induced NF-kappaB activation. J Biol Chem 2008, 283:24295-24299.
21. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumor suppressor CYLD negatively regulates NF-κB signaling pathway by deubiquitination. Nature 2003, 424:801-805.
22. Alameda J.P., Moreno-Maldonado R., Navarro M., et al. An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene 2010, 29:6522-6532.
23. Urbanik T., Kohler B.C., Boger R.J., et al. Down-regulation of CYLD as a trigger for NF-κ activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells. Int J Oncol 2011, 38:121-131.
24. Wertz I.E., O'Rourke K.M., Zhou H., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 2004, 430:694-699.
25. Shembade N., Ma A., Harhaj E.W. Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010, 327:1135-1139.
26. Ea C.K., Deng L., Xia Z.P., Pineda G., Chen Z.J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin by NEMO. Mol Cell 2006, 22:245-257.
27. Wong W.W., Gentle I.E., Nachbur U., Anderton H., Vaux D.L., Silke J. RIPK1 is not essential for TNFR1-induced activation of NF-κB. Cell Death Differ 2010, 17:482-487.
28. Lee T.H., Shank J., Cusson N., Kelliher M.A. The kinase activity of Rip1 is not required for tumor necrosis factor-α-induced IκB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J Biol Chem 2004, 279:33185-33191.
29. Schneider-Brachert W., Tchikov V., Merkel O., et al. Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J Clin Invest 2006, 116:2901-2913.
30. Bertrand M.J., Milutinovic S., Dickson K.M., et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promotes RIP1 ubiquitination. Mol Cell 2008, 30:689-700.
31. Lin Y., Choksi S., Shen H.M., et al. Tumor necrosis factor-induced non-apoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 2004, 279:10822-10828.
32. Chan F.K., Shisler J., Bixby J.G., et al. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 2003, 278:51613-51621.
33. Osborn S.L., Diehl G., Han S.J., et al. Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc Natl Acad Sci USA 2010, 107:13034-13039.
34. Ermolaeva M.A., Michallet M.C., Papadopoulou N., et al. Function of TRADD in tumor necrosis factor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 2008, 9:1037-1046.
35. Wang L., Du F., Wang X. TNF-alpha induced two distinct caspase-8 activation pathways. Cell 2008, 133:693-703.
36. Kim J.W., Choi E.J., Joe C.O. Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene 2000, 19:4491-4499.
37. Feng S., Yang Y., Mei Y., et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal 2007, 19:2056-2067.
38. Declercq W., Vanden Berghe T., Vandenabeele P. RIP kinases at the crossroads of cell death and survival. Cell 2009, 138:229-232.
39. Cho Y.S., Challa S., Moquin D., et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulated programmed necrosis and virus-induced inflammation. Cell 2009, 137:1112-1123.
40. Sun X., Lee J., Navas T., Baldwin D.T., Stewart T.A., Dixit V.M. RIP3, a novel apoptosis-induing kinase. J Biol Chem 1999, 274:16871-16875.
41. Zhao L., Wang G., Lu D., et al. Homocysteine, hRIP3 and congenital cardiovascular malformations. Anat Embryol 2006, 211:203-212.
42. Newton K., Sun X., Dixit V.M. Kinase RIP3 is dispensable for normal NF-κB, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptor 2 and 4. Mol Cell Biol 2004, 24:1464-1469.
43. He S., Wang L., Miao L., et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 2009, 137:1100-1111.
44. Cho Y., Challa S., Chan F.K. A RNA interderence screen identifies RIP3 as an essential inducer of TNF-induced programmed necrosis. Adv Exp Med Biol 2011, 691:589-593.
45. Sun X., Yin J., Starovasnik M.A., Fairbrother W.J., Dixit V.M. Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3. J Biol Chem 2002, 277:9505-9511.
46. Upton J.W., Kaiser W.J., Mocarski E.S. Virus inhibition of RIP3-dependent necrosis. Cell Host Microbe 2010, 7:321-413.
47. Wu Y.T., Tan H.L., Huang Q., Sun X.J., Zhu X., Shen H.M. zVAD-induced necroptosis in L929 cells depends on autocrine production of TNF-α mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ 2011, 18:26-37.
48. Petersen S.L., Wang L., Yalcin-Chin A., et al. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 2007, 12:445-456.
49. Vercammen D., Brouckaert G., Denecker G., et al. Dual signaling of the Fas receptor:initiation of both apoptotic and necrotic cell death pathways. J Exp Med 1998, 188:919-930.
50. Degterev A., Huang Z., Boyce M., et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol 2005, 1:112-119.
51. Xu X., Chua K.W., Chua C.C., Liu C.F., Hamdy R.C., Chua B.H. Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury. Brain Res 2010, 1355:189-194.
52. Rosenbaum D.M., Degterev A., David J., et al. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 2010, 88:1569-1576.
53. Hsu T.S., Yang P.M., Tsai J.S., Lin L.Y. Attenuation of cadmium-induced necrotic cell death by necrostatin-1: potential necrostatin-1 acting sites. Toxicol Appl Pharmacol 2009, 235:153-162.
54. Wang K., Li J., Degterev A., Hsu E., Yuan J., Yuan C. Structure-activity relationship of a novel necroptosis inhibitor, necrostatin-5. Bioorg Med Chem Lett 2007, 17:1455-1465.
55. Zheng W., Degterev A., Hsu E., Yuan J., Yuan C. Structure-activity relationship of a novel necroptosis inhibitor, necrostatin-7. Bioorg Med Chem Lett 2008, 18:4923-4935.
56. Berghe T.V., Vanlangenakker N., Parghoens E., et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ 2010, 17:922-930.
57. Morgan M.J., Kim Y.S., Liu Z. Lipid rafts and oxidative stress-induced cell death. Antioxid Redox Signal 2007, 9:1471-1483.
58. Sakon S., Xue X., Takekawa M., et al. NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J 2003, 22:3898-3909.
59. Jezek P., Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol 2005, 37:2478-2503.
60. Chen Q., Vazquez E.J., Moghaddas S., Hoppel C.L., Lesnefsky E.J. Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 2003, 278:36027-36031.
61. Zhang D.W., Shao J., Lin J., et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009, 325:332-336.
62. Nicotera P., Melino G. Regulation of the apoptosis-necrosis switch. Oncogene 2004, 23:2757-2765.
63. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004, 4:181-189.
64. Kim Y.S., Morgan M.J., Choksi S., Liu Z.G. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 2007, 26:675-687.
65. Dang P.M., Stensballe A., Boussetta T., et al. A specific p47phox-serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J Clin Invest 2006, 116:2033-2043.
66. Li L., He Q., Huang X., et al. Nox3-derived reactive oxygen species promote TNF-alpha-induced reductions in hepatocyte glycogen levels via a JNK pathway. FEBS Lett 2010, 584:995-1000.
67. Moe K.T., Aulia S., Jiang F., et al. Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells. J Cell Mol Med 2007, 10:231-239.
68. Ventura J.J., Cogswell P., Flavell R.A., Baldwin A.S., Davis R.J. JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev 2004, 18:2905-2915.
69. Shen H.M., Lin Y., Choksi S., et al. Essential role of receptor-interacting protein and TRAF2 in oxidative stress-induced cell death. Mol Cell Biol 2004, 24:5914-5922.
70. Xu Y., Huang S., Liu Z.G., Han J. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-medited JNK1 activation. J Biol Chem 2006, 281:8788-8795.
71. Lee S.Y., Reichlin A., Santana A., Sokol K.A., Nussenzweig M.C., Choi Y. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival. Immunity 1997, 7:703-713.
72. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239-252.
73. Nakagawa T., Shimizu S., Watanabe T., et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434:652-658.
74. Temkin V., Huang Q., Liu H., Osada H., Pope R.M. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol Cell Biol 2006, 26:2215-2225.
75. Schubert A., Grimm S., Cyclophilin D. A component of the permeability transition-pore, is an apoptosis repressor. Cancer Res 2004, 64:85-93.
76. Baines C.P., Kaiser R.A., Purcell N.H., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
77. Bredt D.S. Endogenous nitric oxide synthesis:biological functions and pathophysiology. Free Radic Res 1999, 31:577-596.
78. van der Vliet A., Eiserich J.P., Cross C.E. Nitric oxide: a pro-inflammatory mediator in lung disease?. Respir Res 2000, 1:67-72.
79. Zheng J., Wen Y., Austin J.L., Chen D.B. Exogenous nitric oxide stimulates cell proliferation via activation of a mitogen-activated protein kinase pathway in ovine fetoplacental artery endothelial cells. Biol Reprod 2006, 74:375-382.
80. Uehara T., Nakamura T., Yao D., et al. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006, 441:513-517.
81. Burwell L.S., Brookes P.S. Mitochondria as a target for the cardioprotective effects of nitric oxide in ischemia-reperfusion injury. Antioxid Redox Signal 2008, 10:579-599.
82. Cooper C.E., Giulivi C. Nitric oxide regulation of mitochondrial oxygen consumption II: molecular mechanism and tissue physiology. Am J Physiol Cell Physiol 2007, 292:C1993-C2003.
83. Moncada S., Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat Rev Mol Cell Biol 2002, 3:214-220.
84. Davis C.W., Hawkins B.J., Ramasamy S., et al. Nitration of the mitochondrial complex I subunit NDUFB8 elicits RIP1-and-RIP3-mediated necrosis. Free Radic Biol Med 2010, 48:306-317.
85. 2. Biol Pharm Bull 2004, 27:1174-1178.
86. 2 translocation to internal membranes. J Biol Chem 2001, 276:30150-30160.
87. 2 by MNK1-related protein kinases. J Biol Chem 2000, 275:37542-37551.
88. Hayakawa M., Ishida N., Takeuchi K., et al. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 1993, 26:11290-11295.
89. 2. J Immunol 2000, 165:6756-6761.
90. Kohjimoto Y., Kennington L., Scheid C.R., Honeyman T.W. Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kidney Int 1999, 56:1432-1441.
91. van Leyen K., Duvoisin R.M., Engelhardt H., Wiedmann M. A function for lipoxygenase in programmed organelle degradation. Nature 1998, 395:392-395.
92. Maccarrone M., Melino G., Finazzi-Agro A. Lipoxygenases and their involvement in programmed cell death. Cell Death Differ 2001, 8:776-784.
93. Festjens N., Kalai M., Smet J., et al. Butylated hydroxyanisole is more than a reactive oxygen species scavenger. Cell Death Differ 2006, 13:166-169.
94. Wu Z., Wu L.J., Li L.H., Tashiro S., Onodera S., Ikejima T. Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis. J Asian Nat Prod Res 2004, 6:155-166.
95. Han W., Li L., Qiu S., et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther 2007, 6:1641-1649.
96. Horita H., Frankel A.E., Thorburn A. Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms. PLoS One 2008, 12:e3909.
97. Han W., Xie J., Li L., Liu Z., Hu X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis 2009, 14:674-686.
98. Wu Y.T., Tan H.L., Huang Q., Kim Y.S., Pan N., Ong W.Y. Autophagy plays a protective role during zVAD-induced necrotic cell death. Autophagy 2008, 4:457-466.
99. Bell B.D., Leverrier S., Weist B.M., et al. FADD and caspase-8 control the outcome of autophagic signaling in proliferation T cells. Proc Natl Acad Sci USA 2008, 105:16677-16682.
100. Bonapace L., Bornhauser B.C., Schmitz M., et al. Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Invest 2010, 120:1310-1323.
101. Shiraishi H., Okamoto H., Hara H., Yoshida H. Alternative cell death of Apaf1-deficient neural progenitor cells withdrawal of EGF or insulin. Biochim Biophys Acta 2010, 1800:405-415.
102. Yu L., Alva A., Su H., et al. Regulation of an ATG7-belin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.
103. Chen S.Y., Chiu L.Y., Maa M.C., Wang J.S., Chien C.L., Lin W.W. zVAD-induced autophagic cell death requires c-Src-dependent ERK and JNK activation and reactive oxygen species generation. Autophagy 2011, 7:217-228.
104. Yu L., Wan F., Dutta S., et al. Autophagic programmed cell death by selective catalase degradation. Proc Natl Acad Sci USA 2006, 103:4952-4957.
105. Xu Y., Kim S.O., Li Y., Han J. Autophagy contributes to caspase-independent macrophage cell death. J Biol Chem 2006, 281:19179-19187.
106. Kim J.Y., Kim Y.J., Lee S., Park J.H. BNip3 is a mediator of TNF-induced necrotic cell death. Apoptosis 2011, 16:114-126.
107. Cao G., Xing J., Xiao X., et al. Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J Neurosci 2007, 27:9278-9293.
108. Ye H., Cande C., Stephanou N.C., et al. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 2002, 9:680-684.
109. Xu X., Chua C.C., Kong J., et al. Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells. J Neurochem 2007, 103:2004-2014.
110. Xu X., Chua C.C., Zhang M., et al. The role of PARP activation in glutamate-induced necroptosis in HT-22 cells. Brain Res 2010, 1343:206-212.
111. Li M., Beg A.A. Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells. J Virol 2000, 74:7470-7477.
112. Ruby J., Bluethmann H., Peschon J.J. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p57 TNF receptors. J Exp Med 1997, 186:1591-1596.
113. Mack C., Sickmann A., Lembo D., Brune W. Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. Proc Natl Acad Sci USA 2008, 105:3094-3099.
114. Upton J.W., Kaiser W.J., Mocarski E.S. Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1. J Biol Chem 2008, 283:16966-16970.
115. Smith C.C., Davidson S.M., Lim S.Y., Simpkin J.C., Hothersall J.S., Yellon D.M. Necrostatin: a potential novel cardioprotective agent?. Cardiovasc Drugs Ther 2007, 21:227-233.
116. Li Y., Yang X., Ma C., Qiao J., Zhang C. Necroptosis contributes to the NMDA-induced excitotoxicity in rat's cultured cortical neurons. Neurosci Lett 2008, 447:120-123.
117. You Z., Savitz S.I., Yang J., et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2008, 28:1564-1573.
118. Cerhan J.R., Ansell S.M., Fredericksen Z.S., et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007, 110:4455-4463.
119. Mantel F., Frey B., Haslinger S., et al. Combination of lonising irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells. Strahlenther Onkol 2010, 186:587-599.
120. Zhang H., Zhong C., Shi L., Guo Y., Fan Z. Granulysin induces cathepsin B release from lysosomes of target tumor cells to attack mitochondria through processing of bid leading to necroptosis. J Immunol 2009, 182:6993-7000.